Abstract
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): April 09, 2015
This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications for innovative research projects examining the basic and clinical aspects of HIV infection, treatment, and long-term sequelae as they relate to the mission of the Division of Kidney, Urologic and Hematologic Diseases within NIDDK (KUH/NIDDK).
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-020.html.
Limited Competition for the Continuation of the SEARCH for Diabetes in Youth Cohort Study (UC4): RFA-DK-14-508
National Institute of Diabetes and Digestive and Kidney Diseases
National Center for Chronic Disease Prevention and Health Promotion
Application Receipt Date(s): March 10, 2015
The purpose of this Funding Opportunity Announcement (FOA)is to continue the SEARCH for Diabetes in Youth Study. The overarching goal of SEARCH is to provide population-based data on the incidence and prevalence of diabetes and its complications in U.S. youth. SEARCH has recruited a cohort of youth with diabetes who have been followed longitudinally. The purpose of this FOA is to continue follow-up of the SEARCH cohort to understand the clinical course of youth-onset diabetes, including the incidence of acute and chronic complications, including mortality, and processes of care and quality of life.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-508.html.
Definition of Resilience and Pre-Symptomatic Disease in Lung Health and Disease (R01): RFA-HL-15-024
National Heart, Lung, and Blood Institute
Application Receipt Date(s): January 21, 2015
The purpose of this FOA is to invite applications that will seek to prospectively define and/or validate pulmonary or immune system attributes associated with pre-symptomatic disease states or resilience, with the goal of informing the development of primary prevention strategies for chronic lung diseases. -
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-15-024.html.
Pre-Symptomatic Profiles of Chronic Lung Disease(s) from Retrospective Cohorts (R21): RFA-HL-15-025
National Heart, Lung, and Blood Institute
Application Receipt Date(s): January 21, 2015
Research applications are requested that stimulate focused secondary analyses of existing clinical research datasets to test innovative hypotheses about the epidemiology of incident chronic lung disease(s). Novel analyses of existing data will generate clinical and/or biological phenotypes of the pre-symptomatic stages of chronic lung disease(s) and serve as preliminary data for subsequent research applications on primary prevention.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-15-025.html.
Hepatitis C Cooperative Research Centers: Immunity to HCV Infection (U19): RFA-AI-14-045
National Institute of Allergy and Infectious Diseases
Funding Opportunity Purpose
The purpose of the Funding Opportunity Announcement (FOA) is to support research on the host immunological response to Hepatitis C Virus (HCV) infection with the goal of defining the immune requirements critical to a) protection against HCV infection, and b) successful clearance of HCV infection, conducted through Hepatitis C Cooperative Research Centers (HepC Center(s)).
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-045.html.
Studies of HIV in Digestive Diseases Limited to Gastrointestinal Mucosal Immunology and Liver Diseases (R01): RFA-DK-14-019
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): April 07, 2015
The goal of this Funding Opportunity Announcement (FOA) is to support innovative research with human subjects to elucidate the role of gastrointestinal mucosal immunity during HIV infection, to evaluate pathophysiologic mechanisms of injury to the liver and the biliary system during HIV infection, and to conduct epidemiological studies of liver diseases and disorders in HIV patients. Proposed projects must involve individuals with HIV infection or materials or data from HIV-infected individuals.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-019.html.
System-Level Health Services and Policy Research on Health Disparities (R01): RFA-MD-15-001
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): January 20, 2015
The purpose of this Funding Opportunity Announcement (FOA) is to solicit innovative system-level health services and policy research that can directly and demonstrably contribute to the elimination of health disparities.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-15-001.html.
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42): RFA-MD-15-003
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): January 23, 2015
This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop a product, process or service for commercialization with the aim of reducing disparities in healthcare access and health outcomes. Appropriate technologies should be effective, affordable, culturally acceptable, and deliverable to racial/ethnic minorities, low-income and rural populations.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-15-003.html.
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43): RFA-MD-15-004
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): January 27, 2015
This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a product, process or service for commercialization with the aim of reducing disparities in healthcare access and health outcomes. Appropriate technologies should be effective, affordable, culturally acceptable, and deliverable to racial/ethnic minorities, low-income and rural populations.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-15-004.html.
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers (CSCPDPC -CCs) (U01): RFA-DK-14-027
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Application Receipt Date(s): April 02, 2015
This Funding Opportunity Announcement (FOA) invites U01 applications for the establishment of a clinical consortium, composed of one Coordination and Data Management Center (CDMC) and up to 9 Clinical Centers (CC), to conduct studies on chronic pancreatitis (CP) and factors that increase the risk of pancreatic cancer in patients (children and adults) with CP, pancreatogenic (type 3c) diabetes (T3cDM) and in patients with newly diagnosed diabetes.
The Consortium will form multi-disciplinary teams composed of members from the CCs and CDMC to undertake a comprehensive clinical, epidemiological and biological characterization of patients with CP (including those with Acute Recurrent Pancreatitis, ARP) to gain insight into the pathophysiology of chronic pancreatitis and its sequela: chronic pain, pancreatic insufficiency, T3cDM and the diabetes/pancreatic cancer association. The teams will also undertake studies on the development of pancreatic cancer in newly diagnosed diabetic patients.
Applications for the Consortium Coordination and Data Management Center (CDMC) are being solicited via RFA-DK-14-028 “Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Coordination and Data Coordinating Center (CSCPDPC-CDMC) (U01)”.
To achieve the goal of a comprehensive characterization of evolving chronic pancreatitis and pancreatic cancer, each CC should include researchers and clinicians with multi-disciplinary expertise. Research CCs will be expected to share results freely within Consortium and to develop trans-Consortium collaborative projects that make use of the combined expertise and technological capabilities present in all of the CCs.
In addition, a major collaborative effort within the Consortium will be the establishment of an annotated repository of biospecimens (blood, pancreatic and duodenal juice, stools and when feasible pancreatic tissue) to allow for the identification and validation of biomarkers for risk stratification and/or early detection.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-027.html.
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Coordination and Data Management Center (CSCPDPC- CDMC) (U01): RFA-DK-14-028
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Application Receipt Date(s): April 02, 2015
This Funding Opportunity Announcement (FOA) invites U01 applications for the establishment of a clinical consortium, composed of one Coordination and Data Management Center (CDMC) and up to 9 Clinical Centers (CC), to conduct studies on chronic pancreatitis (CP) and factors that increase the risk of pancreatic cancer in patients (children and adults) with CP, pancreatogenic (type 3c) diabetes (T3cDM) and in patients with newly diagnosed diabetes.
The Consortium will form multi-disciplinary teams composed of members from the CCs and CDMC to undertake a comprehensive clinical, epidemiological and biological characterization of patients with CP (including those with Acute Recurrent Pancreatitis, ARP) to gain insight into the pathophysiology of chronic pancreatitis and its sequela: chronic pain, pancreatic insufficiency, T3cDM and the diabetes/pancreatic cancer association. The teams will also undertake studies on the development of pancreatic cancer in newly diagnosed diabetic patients.
Applications for the consortium Clinical Centers are being solicited via RFA-DK-14-027 “Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers (CSCPDPC-CCs) (U01)”.
To achieve the goal of a comprehensive characterization of evolving chronic pancreatitis and pancreatic cancer, the Coordinating and Data Management Center (CDMC) will take on the administrative and data collection/analysis functions and will be responsible for the conduct of all of the ongoing and future studies of the CCs.
In addition, a major collaborative effort within the Consortium will be the establishment of an annotated repository of bio-specimens (blood, pancreatic and duodenal juice, stools and when feasible pancreatic tissue) to allow for the identification and validation of biomarkers for risk stratification and/or early detection.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-028.html.
Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01): PAR-15-020
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt/Submission Date(s): January 15, 2015, November 10, 2015, November 10, 2016
The purpose of this funding opportunity announcement (FOA) is to promote systems developmental biology. In the context of this FOA, systems developmental biology is defined as research focused on understanding how biological components work together to produce the complex biological phenomena encompassing embryonic development.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PAR-15-020.html.
Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01): RFA-DK-14-023
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): April 09, 2015
The goal of this Funding Opportunity Announcement (FOA) is to support innovative research in humans to elucidate the role of HIV infection, including relevant host conditions or antiretroviral therapy, on metabolic and endocrine dysfunction, as well as to support innovative research delineating the pathophysiology, etiology, risk or protective factors, and potential strategies to prevent, treat, or reverse endocrine and metabolic dysfunction in HIV-infected individuals. Proposed projects must involve human subjects with HIV infection or materials or data from HIV-infected individuals. Proposed projects must also be related to the mission of the Division of Diabetes, Endocrinology, and Metabolic Diseases within NIDDK (DEM/NIDDK).
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-023.html.
Development and Translation of Medical Technologies to Reduce Health Disparities (SBIR) (R43/R44): RFA-EB-15-001
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Application Due Date(s): January 28, 2015; May 28, 2015 AIDS Application Due Date(s): May 7, 2015; September 7, 2015
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop and translate medical technologies aimed at reducing disparities in healthcare access and health outcomes. Appropriate medical technologies should be effective, affordable, culturally acceptable, and deliverable to those who need them. Responsive grant applications must involve a formal collaboration with a healthcare provider or other healthcare organization serving one or more health disparity populations during Phase I and Phase II.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-EB-15-001.html.
Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01): RFA-FD-15-001
Food and Drug Administration
Office of Orphan Products Development
Application Receipt Date(s): Application Due Date(s): February 4, 2015; February 3, 2016; February 1, 2017; February 7, 2018 by 11:59 PM Eastern Time. Resubmission Due Date(s): October 15, 2015; October 14, 2016; October 16, 2017; October 15, 2018) by 11:59 PM Eastern Time.
The goal of FDA's OPD grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the product being developed will be superior to the existing therapy. FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application's Background and Significance section documentation to support the assertion that the orphan disease or condition to be studied is a “rare disease or condition” and an explanation of how the proposed study will either help support product approval or provide essential data needed for product development.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-15-001.html.
NIH Director's Early Independence Awards (DP5): RFA-RM-14-004
NIH Roadmap Initiatives
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): January 30, 2015
The NIH Director's Early Independence Award Program supports exceptional investigators who wish to pursue independent research directly after completion of their terminal doctoral/research degree or clinical residency, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career.
Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-14-004.html.
Administrative Supplements for Human Islet Research (Admin Supp): PA-15-025
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt/Submission Date(s): January 15, 2015, April 15, 2015, October 15, 2015
NIDDK announces the availability of administrative supplements to support increased costs for human islets levied by the Integrated Islet Distribution Program. Requests will be considered and awarded on a case-by-case basis based on need and justification.
Complete details available at: http://grants.nih.gov/grants/guide/pa-files/PA-15-025.html.